• “Celgene Corporation illegally prevented a generic version of their drugs from coming to market,” said David Mitchell, the lead patient in the lawsuit and founder of Patients For Affordable Drugs. “The company’s behavior hurts patients, keeps prices high, and costs taxpayers millions. Celgene is callously taking advantage of patients—many of whom are fighting for their lives—because Revlimid accounts for 63 percent of its revenue.”

    Mitchell was diagnosed with multiple myeloma in November of 2010. He took Revlimid for more than five years to keep his cancer at bay. Over that time, the price of Revlimid increased 34 percent and Mitchell’s co-payments jumped by 600 percent.

    During Mitchell’s treatment, Celgene refused to provide samples of Revlimid to generic manufacturers that planned to bring a cheaper competitor to market, among its other abuses of the law. Celgene has hidden behind the bogus pretext of a risk evaluation and mitigation strategy – a system designed to ensure dangerous drugs are distributed and used safely, not to block their distribution at lower prices.

    The Food and Drug Administration (FDA)and the Federal Trade Commission (FTC)called Celgene’s practice into question. The FDA told Celgene that risk evaluation and mitigation should not stand in the way of making samples available to generic manufacturers. The FTC stated: “If brand firms are able to block generic competition by denying access to the product samples needed to obtain FDA approval, this conduct may prevent the (law) from functioning as Congress intended.” In fact, Congress is considering bipartisan legislation right now to stop these types of abuses.

    “Celgene’s behavior wasn’t about safety, it was about protecting its monopoly, propping up its stock, and pocketing billions in profits,” Mitchell said. As a reward for executing this illegal strategy, the former CEO of Celgene—Robert Hugin—received almost $100 million in compensation over a three-year period and was promoted to Chairman.
    Mitchell made clear he personally wants no money from the suit. His goal is to stop Celgene’s anti-competitive behavior, help lower drug prices, and win restitution for patients.

    “If we win this suit, I will donate every penny that I receive in damages to non-profits that support cancer research and lower drug prices,” Mitchell said. “This is about ending bad behavior by drug corporations and helping patients live longer.”

    Patients For Affordable Drugs is the nation’s only independent patient organization focused exclusively on policies to lower prescription drug prices. It does not accept funding from any organizations that profit from the development or distribution of prescription drugs. The next step in the legal process is for a judge to certify the class pursuing the action against Celgene Corporation.


    Comments are closed

    Sorry, but you cannot leave a comment for this post.


    Latest Posts

    Latest Video



    What To Expect When Going To A Local Therapist

    Much of the population still looks down on therapy and psychologists. The primary reason for this is that therapy is vastly misunderstood by the general…

    Calm Body and Calm Mind: 4 Stress-Relief Strategies You Can Try

    Stress comes in different ways. First, stress can be in the form of acute stress. Acute stress is the kind of stress that you acquire,…

    Programming the Subconscious to Fight Diabetes

    Diabetes is a life-threatening illness that causes strokes, heart attacks, kidney failure, and blindness. Every year, 1.5 million Americans learn they have the illness. For…

    Vision of the Future in AR and Mixed Reality

    SOURCE Hello everyone who is reading our blog In this post I would like to share some of my thoughts and observations on how different…

    Keeping out of Trouble: 3 Scenarios Where Health Insurance Can Drop You

    Your health insurance is incredibly important, which is why the idea of being dropped by your insurance company is so concerning. Your health insurance provider…

    Health Benefits Associated With Drinking Water

      Out all the things that we eat and drink, water stands out as the most important one. When you drink water the body is…

    Artificial Intelligence Diagnoses Heart Murmurs Better Than Expert Cardiologists

    SOURCE Eko’s heart murmur detection algorithm outperformed four out of five cardiologists for the detection of heart murmurs in a recent clinical study. The algorithm…